Holocene Advisors, LP Bolt Biotherapeutics, Inc. Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.41 - $2.91 $1.64 Million - $3.39 Million	-1,164,927 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $279,101 - $490,974	-101,862 Reduced 8.04%	1,164,927 $3.19 Million
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $443,255 - $1.48 Million	105,789 Added 9.11%	1,266,789 $6.21 Million
Q3 2021 Nov 15, 2021	BUY	$11.15 - $18.6 $888,108 - $1.48 Million	79,651 Added 7.37%	1,161,000 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $8.86 Million - $18.1 Million	575,159 Added 113.63%	1,081,349 $16.7 Million
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $13.1 Million - $20.2 Million	506,190 New	506,190 $16.7 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $19.2M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.